Log in to save to my catalogue

Actavis' pending acquisition of Allergan approved by European Commission

Actavis' pending acquisition of Allergan approved by European Commission

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1664124791

Actavis' pending acquisition of Allergan approved by European Commission

About this item

Full title

Actavis' pending acquisition of Allergan approved by European Commission

Publisher

London: Normans Media Ltd

Journal title

M2 EquityBites, 2015

Language

English

Publication information

Publisher

London: Normans Media Ltd

More information

Scope and Contents

Contents

M2 EQUITYBITES-March 18, 2015-Actavis' pending acquisition of Allergan approved by European Commission (C)1994-2015 M2 COMMUNICATIONS http://www.m2.com Pharmaceutical company Actavis (NYSE:

Alternative Titles

Full title

Actavis' pending acquisition of Allergan approved by European Commission

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_1664124791

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1664124791

How to access this item